We report higher amyloid-β and p-tau load in LATE-NC LBD compared with non-LATE-NC LBD donors, which is in line with earlier studies that found higher AD co-pathology in LATE-NC LBD compared with non-LATE-NC LBD individuals.12,53 Several studies also found increased Lewy body pathology in LATE-NC AD donors compared with non-LATE-NC AD donors,2,5 however, we did not replicate this finding. This evidence concerns the gene MAPT and Alzheimer disease.